SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-048534
Filing Date
2024-04-18
Accepted
2024-04-18 06:16:55
Documents
9
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2411865-1_def14.htm DEF 14A 821949
2 GRAPHIC fc_connect-4c.jpg GRAPHIC 67937
3 GRAPHIC ic_internet-4c.jpg GRAPHIC 7577
4 GRAPHIC ic_laptop-4c.jpg GRAPHIC 3200
5 GRAPHIC ic_mail-4c.jpg GRAPHIC 4550
6 GRAPHIC ic_telephone-4c.jpg GRAPHIC 4920
7 GRAPHIC lg_sagimetbio-4clr.jpg GRAPHIC 27050
8 GRAPHIC px_sagimetproxy1pg01-bw.jpg GRAPHIC 381454
9 GRAPHIC px_sagimetproxy1pg02-bw.jpg GRAPHIC 166755
  Complete submission text file 0001104659-24-048534.txt   1686007
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41742 | Film No.: 24852740
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)